Stephen Thau

Morrison & Foerster LLP

+ Follow Contact

Latest Posts › Valuation

Share:

MoFo BioMeter - Volume 2, Issue 2: May 2013 - Flat BioMeter Value and Decline in Deal Volume are Hallmarks of Q1

The Morrison & Foerster BioMeter for the first quarter of 2013 shows a flat quarter for BioMeter value and a decline in dealmaking activity. A small number of large deals dominate an otherwise quiet quarter. In the...more

5/31/2013 / Biotechnology , Over The Counter Derivatives (OTC) , Pharmaceutical Industry , Prescription Drugs , Valuation

1 Results

View per page

Page: of 1

Stephen Thau

Morrison & Foerster LLP

Popular Topics by This Author

Latest Posts › Valuation

MoFo BioMeter - Volume 2, Issue 2: May 2013 - Flat BioMeter Value and Decline in Deal Volume are Hallmarks of Q1

"My best business intelligence, in one easy email…"